Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-28 Purchase |
2023-11-30 4:05 pm |
Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director |
10,000 | $0.6486 | $6,486 | 50,000 (Direct) |
View |
| 2023-11-21 Purchase |
2023-11-22 4:06 pm |
Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director |
10,000 | $0.6383 | $6,383 | 40,000 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-20 8:14 pm |
Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director |
30,000 | $0.608 | $18,240 | 30,000 (Direct) |
View |
| 2022-12-05 Purchase |
2022-12-07 4:29 pm |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
12,500 | $1.09 | $13,625 | 50,000 (Direct) |
View |
| 2022-12-01 Purchase |
2022-12-05 4:21 pm |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
37,500 | $1.05 | $39,375 | 37,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-06 Option Award |
2024-06-10 6:20 pm |
2025-06-06 2034-06-06 |
Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 9:45 pm |
N/A 2034-06-05 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:18 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2023-11-01 Option Award |
2023-11-02 6:00 pm |
N/A 2033-11-01 |
Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-08-31 Equity Swap |
2023-08-31 2:55 pm |
N/A N/A |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
50,000 | $0 | 0 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:50 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:36 pm |
N/A 2033-02-01 |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
562,500 | $0 | 562,500 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:34 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-10-14 Equity Swap |
2022-10-14 4:06 pm |
N/A N/A |
Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director |
7,250 | $0 | 0 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 4:17 pm |
N/A 2032-09-14 |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:44 pm |
N/A 2032-06-09 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:34 pm |
N/A 2032-06-07 |
Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director |
11,250 | $0 | 14,000 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:40 pm |
N/A 2032-03-01 |
PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer |
985,000 | $0 | 985,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:54 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 7:05 pm |
N/A 2031-06-16 |
Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director |
11,125 | $0 | 11,125 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:12 pm |
N/A 2031-06-02 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-05 5:01 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-09-07 Option Award |
2020-09-09 4:05 pm |
N/A 2030-09-06 |
Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director |
25,000 | $0 | 0 (Direct) |
View |
Ownership |
2020-07-23 4:57 pm |
N/A 2027-02-28 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
0 | $0 | 31,745 (Direct) |
View |